United States v. Robert P. Popovich, Jack W. Moncrief, and the University of Texas System

820 F.2d 134, 3 U.S.P.Q. 2d (BNA) 1370, 1987 U.S. App. LEXIS 8085
CourtCourt of Appeals for the Fifth Circuit
DecidedJune 26, 1987
Docket86-1686
StatusPublished
Cited by31 cases

This text of 820 F.2d 134 (United States v. Robert P. Popovich, Jack W. Moncrief, and the University of Texas System) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Robert P. Popovich, Jack W. Moncrief, and the University of Texas System, 820 F.2d 134, 3 U.S.P.Q. 2d (BNA) 1370, 1987 U.S. App. LEXIS 8085 (5th Cir. 1987).

Opinion

POLITZ, Circuit Judge:

The United States filed a declaratory action against Robert P. Popovich, Jack W. Moncrief, and the University of Texas System (UTS), seeking a declaration that it is entitled to a certain patent issued to Popovich and Moncrief and the imposition of a constructive trust on all funds derived from the patent. The district court granted judgment in favor of Popovich and Moncrief, finding that the claims of the United States were barred by the doctrine of laches and by the Administrative Procedure Act (APA). The demands against UTS were dismissed under Fed.R.Civ.P. 12(b)(6) for failure to state a claim upon which relief could be granted. We reverse and remand.

Background

In 1973 the Department of Health, Education, and Welfare, now Health and Human Services (HHS), awarded UTS a research contract. Popovich, an assistant professor of chemical and biomedical engineering at the University of Texas at Austin, was named the principal investigator, and Moncrief, a physician in the private practice of nephrology and not connected with UTS, was the co-investigator of the research. The contract called for intensive research into peritoneal dialysis.

In peritoneal dialysis, the blood of patients with renal insufficiency is cleansed of toxins by the infusion of a solution directly into the abdominal cavity, for interaction with the blood supply across the peritoneal membrane. Traditional hemodialysis requires removal of the blood for cleansing, a process which is more traumatic and far more expensive. The grant called for the development of mathematical models, in order “to obtain a fundamental understanding of the mass transfer-molecular weight characteristics of peritoneal dialysis,” and “to optimize peritoneal dialysis dosage cycles and schedules.”

The contract is not of record but there is no dispute that it contains a standard clause for contracts of this type, requiring the grantee to notify HHS when an invention is “made in the course of or under” the contract, and making rights in all' such inventions subject to government ownership and disposition. Current HHS regulations similarly provide. See 45 C.F.R. § 8 (1986).

During the term of the contract, Popovich and Moncrief developed a new medical treatment modality for patients suffering acute renal failure, which they called Continuous Ambulatory Peritoneal Dialysis (CAPD). CAPD is distinct from earlier *136 methods of peritoneal dialysis in that it is continuous rather than intermittent, and permits a patient to perform normal activities during treatment. Reportedly, CAPD has become the dominant form of home dialysis, serving approximately 30,000 patients.

Popovich and Moncrief maintain that CAPD was conceived in June 1975, that they disclosed their invention to the HHS contract officer a few months later, and that CAPD is not an invention subject to the provisions of the HHS-UTS contract. In March 1977 a patent was applied for, and in December 1980 patent number 4,239,041 issued to Popovich and Moncrief.

In February 1978 HHS became aware of the pending patent application. During the next six years there were government-initiated investigations, intermittent communications, and unsuccessful settlement efforts, separated by extended periods of inaction by HHS. In February 1984, the instant suit was filed. HHS sought a declaration that the invention was made under the research contract, that it belonged to the United States, and that the government was entitled to an accounting of and a constructive trust over all funds generated by the patent.

Popovich and Moncrief sought summary judgment dismissal because of the delay; UTS sought Fed.R.Civ.P. 12(b)(1) and 12(b)(6) dismissal for lack of jurisdiction and because the claim failed to state a cause of action. The district court granted the summary judgment, finding the government’s delay in filing suit unreasonable because of the time that had elapsed between the disclosure of the invention and the filing of suit, including more than three years after the patent holders' rejection of any settlement. The court assigned no reasons for granting the UTS motion to dismiss under Fed.R.Civ.P. 12(b)(6).

Analysis

Laches

The issue of laches is controlled by a decision of this court apparently overlooked by the district court. In fine, laches may not be asserted as a defense against the United States when it is acting in its sovereign capacity to enforce a public right or protect the public interest. United States v. Arrow Transp. Co., 658 F.2d 392 (5th Cir.1981), cert. denied, 456 U.S. 915, 102 S.Ct. 1769, 72 L.Ed.2d 174 (1982). Relying on United States v. Summerlin, 310 U.S. 414, 416-17, 60 S.Ct. 1019, 1020-21, 84 L.Ed. 1283, 1285-86 (1940), and United States v. Thompson, 98 U.S. (8 Otto) 486, 488-91, 25 L.Ed. 194, 195 (1878), the panel in Arrow reversed the district court’s attempt to “mold a change” in the doctrine. Arrow at 394. Circuit precedent clearly establishes that “laches is unavailable as a defense against the United States in enforcing a public right.” Id. at 395. 1

The holding in Arrow binds the disposition of this panel, as it bound the trial court. Appellees’ attempt to rely on other authority to buttress the application of laches is not persuasive. Prior decisions have recognized laches against the government, but only against the Equal Employment Opportunity Commission in suits filed to recover sums allegedly due to individuals, not the treasury. See, e.g., Occidental Life Insurance Co. v. EEOC, 432 U.S. 355, 97 S.Ct. 2447, 53 L.Ed.2d 402 (1977); Arrow; EEOC v. Griffin Wheel Co., 511 F.2d 456 (5th Cir.1975); EEOC v. Bell Helicopter, 426 F.Supp. 785, 793 (N.D.Tex.1976). In Occidental Life Insurance Co., the Supreme Court resolved prior confusion, recognizing the application of laches in Title VII cases brought by the EEOC. Administrative Procedure Act

The summary judgment dismissal also refers to section 706 of the Administrative Procedure Act, 5 U.S.C. § 706. Entitled “Scope of review,” that section provides in pertinent part:

The reviewing court shall—

(1) compel agency action unlawfully withheld or unreasonably delayed; and

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re: Naoise Ryan
88 F.4th 614 (Fifth Circuit, 2023)
Solenex LLC v. David Bernhardt
962 F.3d 520 (D.C. Circuit, 2020)
Parcha v. Cuccinelli
E.D. Texas, 2020
Mark Javery v. Charles Bolden, Jr.
697 F. App'x 810 (Fifth Circuit, 2017)
In re Wyly
552 B.R. 338 (N.D. Texas, 2016)
Alkenani v. Barrows
356 F. Supp. 2d 652 (N.D. Texas, 2005)
DeGuerin v. United States
214 F. Supp. 2d 726 (S.D. Texas, 2002)
Rowe v. Grapevine Corp.
527 S.E.2d 814 (West Virginia Supreme Court, 1999)
Stockman v. FEC
Fifth Circuit, 1998
Stockman v. Federal Election Commission
138 F.3d 144 (Fifth Circuit, 1998)
Stockman v. Federal Election Commission
944 F. Supp. 518 (E.D. Texas, 1996)
Tregre v. Commissioner
1996 T.C. Memo. 243 (U.S. Tax Court, 1996)
Fein v. United States
22 F.3d 631 (Fifth Circuit, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
820 F.2d 134, 3 U.S.P.Q. 2d (BNA) 1370, 1987 U.S. App. LEXIS 8085, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-robert-p-popovich-jack-w-moncrief-and-the-university-ca5-1987.